Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 0 | 3,659,619 | 3,673,469 | 4,153,380 | 4,076,289 |
| Cost of Goods | 0 | 993,192 | N/A | 4,759,830 | N/A |
| Gross Profit | 0 | 2,666,427 | 3,673,469 | 11,664,290 | 4,076,289 |
| Operating Expenses | 0 | 2,260,243 | 0 | 10,312,940 | 0 |
| Operating Income | 0 | 406,384 | 3,673,469 | -10,918,560 | 4,076,289 |
| Interest Expense | 0 | 47,552 | 0 | 298,250 | 0 |
| Other Income | 0 | 40,680 | 0 | 12,759,050 | 0 |
| Pre-tax Income | 0 | 399,512 | 3,673,469 | 1,542,240 | 4,076,289 |
| Income Tax | 0 | 190,994 | N/A | 478,560 | N/A |
| Net Income Continuous | 0 | 208,518 | -1,892,113 | 155,618 | 259,632 |
| Minority Interests | 0 | 6,937 | N/A | N/A | N/A |
| Net Income | $0 | $201,581 | $-1,892,113 | $155,618 | $259,632 |
| EPS Basic Total Ops | N/A | 0.13 | -1.20 | 0.10 | 0.17 |
| EPS Basic Continuous Ops | N/A | 0.13 | -1.20 | 0.10 | 0.17 |
| EPS Diluted Total Ops | N/A | 0.13 | -1.20 | 0.10 | 0.16 |
| EPS Diluted Continuous Ops | N/A | 0.13 | -1.20 | 0.10 | 0.17 |
| EBITDA(a) | $0 | $406,376 | $3,673,469 | $-10,918,560 | $4,076,289 |